- Analysts at Dougherty initiated coverage on Toro Co TTC with a Buy rating. Toro shares closed at $46.74 on Thursday.
- Cowen & Co. initiated coverage on Array Biopharma Inc ARRY with an Outperform rating. The price target for Array Biopharma is set to $10. Array Biopharma shares closed at $5.38 on Thursday.
- Analysts at Guggenheim initiated coverage of Portland General Electric Company POR with a Neutral rating. Portland General Electric shares closed at $42.51 on Thursday.
- Analysts at Guggenheim initiated coverage of NiSource Inc. NI with a Neutral rating. NiSource shares closed at $22.14 on Thursday.
- Analysts at Macquarie initiated coverage on ALLETE Inc ALE with a Neutral rating. ALLETE shares closed at $59.39 on Thursday.
- Analysts at Longbow Research initiated coverage on Lancaster Colony Corp. LANC with a Neutral rating. Lancaster Colony shares closed at $126.10 on Thursday.
- Analysts at Goldman Sachs initiated coverage on PTC Inc PTC with a Buy rating. The price target for PTC is set to $58. PTC shares closed at $43.25 on Thursday.
- Analysts at Cantor Fitzgerald initiated coverage on AngioDynamics, Inc. ANGO with a Buy rating. The price target for AngioDynamics is set to $19. AngioDynamics shares closed at $15.52 on Thursday.
- Aegis Capital initiated coverage on Ocera Therapeutics Inc OCRX with a Buy rating. The price target for Ocera Therapeutics is set to $8. Ocera Therapeutics shares closed at $2.05 on Thursday.
- Imperial Capital initiated coverage on Red Rock Resorts Inc RRR with an In-Line rating. The price target for Red Rock Resorts is set to $23. Red Rock Resorts shares closed at $21.33 on Thursday.
Loading...
Loading...
ALEALLETE Inc
$65.090.02%
Edge Rankings
Momentum
59.95
Growth
25.86
Quality
17.73
Value
67.26
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in